Page last updated: 2024-11-13

globotetraose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-D-Glcp : A linear amino tetrasaccharide consisting of D-glucose at the reducing end having an N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl moiety attached at the 4-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID53477650
CHEBI ID63013
MeSH IDM0109855

Synonyms (12)

Synonym
(gal)2 (galnac)1 (glc)1
globotetraose
n-acetyl-beta-d-galactosaminyl-(1->3)-alpha-d-galactosyl-(1->4)-beta-d-galactosyl-(1->4)-d-glucose
beta-d-galpnac-(1->3)-alpha-d-galp-(1->4)-beta-d-galp-(1->4)-d-glcp
galnacbeta1-3galalpha1-4galbeta1-4glc
CHEBI:63013
galnacbeta1-3galalpha1-4galbeta1-4glc~oh
beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-d-glc
2-acetamido-2-deoxy-beta-d-galactopyranosyl-(1->3)-alpha-d-galactopyranosyl-(1->4)-beta-d-galactopyranosyl-(1->4)-d-glucopyranose
W-203733
JMPCSGHAAIDYIN-WASRWFGHSA-N
Q27132335
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
amino tetrasaccharideA tetrasaccharide derivative having one or more substituted or unsubstituted amino groups in place of hydroxy groups at unspecified positions.
galactosamine oligosaccharide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.76)18.7374
1990's5 (29.41)18.2507
2000's8 (47.06)29.6817
2010's2 (11.76)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]